Edifoligide and long-term outcomes after coronary artery bypass grafting: PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT IV) 5-year results

American Heart Journal

Volumn 164, Issue 3, 2012, Pages

  Lopes, Renato D ^a   Williams, Judson B ^a,b   Mehta, Rajendra H ^a   Reyes, Eric M ^a   Hafley, Gail E ^a   Allen, Keith B ^c   MacK, Michael J ^d   Peterson, Eric D ^a,b   Harrington, Robert A ^a,b   Gibson, C Michael ^a,e   Califf, Robert M ^b,f   Kouchoukos, Nicholas T ^g   Ferguson, T Bruce ^h   Lorenz, Todd J ⁱ   Alexander, John H ^a,b  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c ST LUKE S HOSPITAL   (United States)

^d Cardiopulmonary Research Science and Technology Institute   (United States)

^e PERFUSE Angiographic Laboratory   (United States)

^f DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g MISSOURI BAPTIST MEDICAL CENTER   (United States)

^h EAST CAROLINA UNIVERSITY   (United States)

ⁱ Department of Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EDIFOLIGIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLACEBO;

ADULT; AGED; ARTICLE; CEREBROVASCULAR DISEASE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DEATH; DIABETES MELLITUS; EX VIVO STUDY; FOLLOW UP; GENETIC TRANSFECTION; HEART INFARCTION; HOSPITAL READMISSION; HUMAN; KAPLAN MEIER METHOD; LUNG DISEASE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RANDOMIZATION; REVASCULARIZATION; SURGICAL MORTALITY; TREATMENT OUTCOME; VEIN GRAFT;

EID: 84866325705     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2012.05.019     Document Type: Article

References (41)

1. K. Allen, D. Cheng, and W. Cohn Endoscopic vascular harvest in coronary artery bypass grafting surgery: a consensus statement of the International Society of Minimally Invasive Cardiothoracic Surgery (ISMICS) Innovations (Phila) 1 2005 51 60
2. A.R. Halabi, J.H. Alexander, and L.K. Shaw Relation of early saphenous vein graft failure to outcomes following coronary artery bypass surgery Am J Cardiol 96 2005 1254 1259 (Pubitemid 41505404)
3. J.H. Alexander, G. Hafley, and R.A. Harrington Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial JAMA 294 2005 2446 2454 (Pubitemid 41627922)
4. P. Widimsky, Z. Straka, and P. Stros One-year coronary bypass graft patency: a randomized comparison between off-pump and on-pump surgery angiographic results of the PRAGUE-4 trial Circulation 110 2004 3418 3423 (Pubitemid 39610503)
5. J.G. Motwani, and E.J. Topol Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention Circulation 97 1998 916 931 (Pubitemid 28113931)
6. V.J. Dzau Predicting the future of human gene therapy for cardiovascular diseases: what will the management of coronary artery disease be like in 2005 and 2010? Am J Cardiol 92 2003 32N 35N (Pubitemid 37412349)
7. A. Ehsan, M.J. Mann, and G. Dell'Acqua Long-term stabilization of vein graft wall architecture and prolonged resistance to experimental atherosclerosis after E2F decoy oligonucleotide gene therapy J Thorac Cardiovasc Surg 121 2001 714 722
8. M.J. Mann, A.D. Whittemore, and M.C. Donaldson Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial Lancet 354 1999 1493 1498 (Pubitemid 29502101)
9. R.C. Braun-Dullaeus, M.J. Mann, and V.J. Dzau Cell cycle progression: new therapeutic target for vascular proliferative disease Circulation 98 1998 82 89 (Pubitemid 28312083)
10. J.H. Alexander, T.B. Ferguson Jr., and D.M. Joseph The PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT IV) trial: study rationale, design, and baseline patient characteristics Am Heart J 150 2005 643 649 (Pubitemid 41396491)
11. D.D. Boos, L.A. Stefanski, and Y. Wu Fast FSR variable selection with applications to clinical trials Biometrics 65 2009 692 700
12. A.M. Wood, I.R. White, and P. Royston How should variable selection be performed with multiply imputed data? Stat Med 27 2008 3227 3246
13. E. Alderman, L.D. Fisher, and P. Litwin Results of coronary artery surgery in patients with poor left ventricular function (CASS) Circulation 68 1983 785 795 (Pubitemid 13019226)
14. European Coronary Surgery Study Group Long-term results of prospective randomised study of coronary artery bypass surgery in stable angina pectoris Lancet 2 1982 1173 1180
15. W.J. Rogers, C.J. Coggin, and B.J. Gersh Ten-year follow-up of quality of life in patients randomized to receive medical therapy or coronary artery bypass graft surgery. The Coronary Artery Surgery Study (CASS) Circulation 82 1990 1647 1658 (Pubitemid 20367966)
16. S. Yusuf, D. Zucker, and P. Peduzzi Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Lancet 344 1994 563 570 (Pubitemid 24267213)
17. M. Murphy, H.N. Hultgren, and K. Detre Treatment of chronic stable angina: a preliminary report of survival data of the randomized Veterans Administration cooperative study N Engl J Med 297 1977 621 627 (Pubitemid 8200047)
18. Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery. Quality of life in patients randomly assigned to treatment groups Circulation 68 1983 951 960
19. Myocardial infarction and mortality in the coronary artery surgery study (CASS) randomized trial N Engl J Med 310 1984 750 758
20. Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina. The Veterans Administration Coronary Artery Bypass Surgery Cooperative Study Group N Engl J Med 311 1984 1333 1339
21. R. Jones, E.J. Velazquez, and R.E. Michler Coronary bypass surgery with or without surgical ventricular reconstruction N Engl J Med 360 2009 1705 1717
22. E.J. Velazquez, K.L. Lee, and M.A. Deja Coronary-artery bypass surgery in patients with left ventricular dysfunction N Engl J Med 364 2011 1607 1616
23. A.P. Kappetein SYNTAX Trial update Paper presented at: Society of Thoracic Surgeons Annual Meeting; January 30, 2012; Ft Lauderdale, FL 2012
24. A. Goyal, J.H. Alexander, and G.E. Hafley Outcomes associated with the use of secondary prevention medications after coronary artery bypass graft surgery Ann Thorac Surg 83 2007 993 1001 (Pubitemid 46331832)
25. T.B. Ferguson Jr., E.D. Peterson, and L.P. Coombs Use of continuous quality improvement to increase use of process measures in patients undergoing coronary artery bypass graft surgery: a randomized controlled trial JAMA 290 2003 49 56 (Pubitemid 37432865)
26. J.B. Williams, E.R. Delong, and E.D. Peterson Secondary prevention after coronary artery bypass graft surgery: findings of a national randomized controlled trial and sustained society-led incorporation into practice Circulation 123 2011 39 45
27. J.B. Cavender, W.J. Rogers, and L.D. Fisher Effects of smoking on survival and morbidity in patients randomized to medical or surgical therapy in the Coronary Artery Surgery Study (CASS): 10-year follow-up. CASS Investigators J Am Coll Cardiol 20 1992 287 294
28. R.H. Jones, E.L. Hannan, and K.E. Hammermeister Identification of preoperative variables needed for risk adjustment of short-term mortality after coronary artery bypass graft surgery. The Working Group Panel on the Cooperative CABG Database Project J Am Coll Cardiol 28 1996 1478 1487 (Pubitemid 26391853)
29. P. Nardi, A. Pellegrino, and A. Scafuri Long-term outcome of coronary artery bypass grafting in patients with left ventricular dysfunction Ann Thorac Surg 87 2009 1401 1407
30. A. Norhammar, K. Malmberg, and E. Diderholm Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization J Am Coll Cardiol 43 2004 585 591 (Pubitemid 38229530)
31. A.J. Tector, T.M. Schmahl, and B. Janson The internal mammary artery graft: its longevity after coronary bypass JAMA 246 1981 2181 2183 (Pubitemid 11030560)
32. V. Vaccarino, and C.G. Koch Long-term benefits of coronary bypass surgery: are the gains for women less than for men? J Thorac Cardiovasc Surg 126 2003 1707 1711 (Pubitemid 38020723)
33. S.E. Woods, G. Noble, and J.M. Smith The influence of gender in patients undergoing coronary artery bypass graft surgery: an eight-year prospective hospitalized cohort study J Am Coll Surg 196 2003 428 434 (Pubitemid 36343644)
34. L. Mosca, C.L. Banka, and E.J. Benjamin Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update Circulation 115 2007 1481 1501 (Pubitemid 46648385)
35. Agency for Healthcare Research and Quality Website. Comparative Effectiveness of Treatments for Women With Coronary Artery Disease. http://www.effectivehealthcare.ahrq.gov/ehc/products/218/613/ Duke%20EPC-Tmt%20of%20Women%20wCAD%20CER-Protocol-2011-01-19.pdf. Last accessed July 11, 2011.
36. B. Maiti, J. Li, and A. de Bruin Cloning and characterization of mouse E2F8, a novel mammalian E2F family member capable of blocking cellular proliferation J Biol Chem 280 2005 18211 18220 (Pubitemid 41389066)
37. X. Cai, and N.J. Freedman New therapeutic possibilities for vein graft disease in the post-edifoligide era Future Cardiol 2 2006 493 501 (Pubitemid 44270119)
38. M.S. Conte Molecular engineering of vein bypass grafts J Vasc Surg 45 2007 A74 A81
39. K.G. Sim, Z. Zang, and C.M. Yang TRIP-Br links E2F to novel functions in the regulation of cyclin E expression during cell cycle progression and in the maintenance of genomic stability Cell Cycle 3 2004 1296 1304 (Pubitemid 40268613)
40. A. Cameron, K.B. Davis, and G. Green Coronary bypass surgery with internal-thoracic-artery grafts - effects on survival over a 15-year period N Engl J Med 334 1996 216 219 (Pubitemid 26030671)
41. R.M. Satava, and R.K. Wolf Disruptive visions: biosurgery Surg Endosc 17 2003 1833 1836 (Pubitemid 37553825)